Showing results (321-330 of 425) with videos related to

Sort By:
Pageof 43
Cancer|March 23, 2023
Nodal positivity and systemic therapy among patients with clinical T1-T2N0 human epidermal growth factor receptor-positive breast cancer: Results from two international cohortsAnna Weiss, Olga Martínez-Sáez, Adrienne G Waks, et al.
Cancer Research Communications|February 9, 2024
Estrogen Receptor Mutations as Novel Targets for Immunotherapy in Metastatic Estrogen Receptor-positive Breast CancerJonathan Goldberg, Na Qiao, Jennifer L Guerriero, et al.
Cancer|May 4, 2018
Risk factors for locoregional disease recurrence after breast-conserving therapy in patients with breast cancer treated with neoadjuvant chemotherapy: An international collaboration and individual patient meta-analysisAntonios Valachis, Eleftherios P Mamounas, Elizabeth A Mittendorf, et al.
JAMA Oncology|June 23, 2022
Prognostic and Biologic Significance of ERBB2-Low Expression in Early-Stage Breast CancerPaolo Tarantino, Qingchun Jin, Nabihah Tayob, et al.
Annals of Surgical Oncology|May 6, 2010
Present-day locoregional control in patients with t1 or t2 breast cancer with 0 and 1 to 3 positive lymph nodes after mastectomy without radiotherapyRanjna Sharma, Isabelle Bedrosian, Anthony Lucci, et al.
Cancer Immunology Research|April 26, 2014
PD-L1 expression in triple-negative breast cancerElizabeth A Mittendorf, Anne V Philips, Funda Meric-Bernstam, et al.
Journal for Immunotherapy of Cancer|October 17, 2022
Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancerAdrienne G Waks, Tanya E Keenan, Tianyu Li, et al.
Clinical Breast Cancer|March 2, 2020
A Phase II Study of Pembrolizumab in Combination With Palliative Radiotherapy for Hormone Receptor-positive Metastatic Breast CancerRomualdo Barroso-Sousa, Ian E Krop, Lorenzo Trippa, et al.
Cancer Cell|January 1, 2021
Integrin αvβ6-TGFβ-SOX4 Pathway Drives Immune Evasion in Triple-Negative Breast CancerArchis Bagati, Sushil Kumar, Peng Jiang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 13, 2024
Integrative Multiomic Profiling of Triple-Negative Breast Cancer for Identifying Suitable TherapiesBojana Jovanović, Sarah E Church, Kara M Gorman, et al.
Pageof 43